Aberrant Expression of FGFRL1 in Esophageal Cancer and Its Regulation by miR-107
暂无分享,去创建一个
[1] Zhen Sun,et al. Lung CSC‐derived exosomal miR‐210‐3p contributes to a pro‐metastatic phenotype in lung cancer by targeting FGFRL1 , 2020, Journal of cellular and molecular medicine.
[2] D M Parkin,et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.
[3] Xiaohui Xu,et al. miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1 , 2018, Oncology letters.
[4] Zhiyong Wu,et al. FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling , 2018, Journal of immunology research.
[5] G. Reid,et al. A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma , 2017, Molecular oncology.
[6] Yingyong Hou,et al. High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients , 2017, Oncotarget.
[7] Rinu Sharma,et al. miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. , 2017, Oncology reports.
[8] Cheng Li,et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..
[9] Yuan Yang,et al. MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. , 2016, Oncology reports.
[10] Razelle Kurzrock,et al. The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing , 2015, Clinical Cancer Research.
[11] J. Zuo,et al. MiR‐210 Links Hypoxia With Cell Proliferation Regulation in Human Laryngocarcinoma Cancer , 2015, Journal of cellular biochemistry.
[12] Huan Liu,et al. MicroRNA‐338‐3p Regulates Osteogenic Differentiation of Mouse Bone Marrow Stromal Stem Cells by Targeting Runx2 and Fgfr2 , 2014, Journal of cellular physiology.
[13] Li Zhang,et al. MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2 , 2014, Experimental & Molecular Medicine.
[14] Heng Zhao,et al. MicroRNA‐198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1 , 2014, Journal of cellular biochemistry.
[15] Lingyi Chen,et al. The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF. , 2014, Carcinogenesis.
[16] T. Betsuyaku,et al. Molecular and Cellular Pathobiology Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3 , 2013 .
[17] Xiuchao Wang,et al. Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. , 2013, Biochemical and biophysical research communications.
[18] M. Humbert,et al. Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.
[19] C. Taylor,et al. An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer , 2013, Genes, chromosomes & cancer.
[20] A. Saraya,et al. Decreased levels of circulating and tissue miR-107 in human esophageal cancer , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[21] Dawn M. Kilkenny,et al. Fibroblast Growth Factor Receptor Like-1 (FGFRL1) Interacts with SHP-1 Phosphatase at Insulin Secretory Granules and Induces Beta-cell ERK1/2 Protein Activation* , 2013, The Journal of Biological Chemistry.
[22] L. Zhuang,et al. Interaction of the receptor FGFRL1 with the negative regulator Spred1. , 2011, Cellular signalling.
[23] J. Wesche,et al. Fibroblast growth factors and their receptors in cancer. , 2011, The Biochemical journal.
[24] G. Tsujimoto,et al. MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)* , 2010, The Journal of Biological Chemistry.
[25] Florian Steinberg,et al. Rapid Fusion and Syncytium Formation of Heterologous Cells upon Expression of the FGFRL1 Receptor* , 2010, The Journal of Biological Chemistry.
[26] N. Turner,et al. Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.
[27] Florian Steinberg,et al. The FGFRL1 Receptor Is Shed from Cell Membranes, Binds Fibroblast Growth Factors (FGFs), and Antagonizes FGF Signaling in Xenopus Embryos* , 2009, The Journal of Biological Chemistry.
[28] Ricky T. Tong,et al. Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. , 2009, Molecular cell.
[29] D. Guidolin,et al. miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. , 2009, Developmental biology.
[30] L. Zhuang,et al. Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient. , 2009, Biochimica et biophysica acta.
[31] R. Lotan,et al. Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer , 2008, Clinical Cancer Research.
[32] J. Luketich,et al. Resection for esophageal cancer: strategies for optimal management. , 2008, The Annals of thoracic surgery.
[33] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[34] Andrew D. Yates,et al. A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.
[35] C. Dickson,et al. Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.
[36] V. P. Eswarakumar,et al. Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.
[37] Robert J Linhardt,et al. Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[38] J. Bonifacino,et al. Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.
[39] L. Zhuang,et al. Characterization of FGFRL1, a Novel Fibroblast Growth Factor (FGF) Receptor Preferentially Expressed in Skeletal Tissues* , 2003, Journal of Biological Chemistry.
[40] J. G. Park,et al. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. , 2001, Cancer research.
[41] B. Trueb,et al. Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. , 2000, Genomics.
[42] Yang Yang,et al. MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. , 2017, American journal of cancer research.
[43] Y. Naito,et al. Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts. , 2010, Biochemical and biophysical research communications.
[44] Peter D Siersema,et al. Esophageal cancer. , 2008, Gastroenterology clinics of North America.